Supplementing preservation solution with mitochondria-targeted H2S donor AP39 protects cardiac grafts from prolonged cold ischemia–reperfusion injury in heart transplantation

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-first pediatric heart transplantation report—2018; Focus theme: Multiorgan Transplantation

Joseph W. Rossano, Wida S. Cherikh, Daniel C. Chambers et al. · The Journal of Heart and Lung Transplantation · 2018 · 638 citations

Medicine, Pediatrics, Surgery +17

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report—2018; Focus Theme: Multiorgan Transplantation

Kiran K. Khush, Wida S. Cherikh, Daniel C. Chambers et al. · The Journal of Heart and Lung Transplantation · 2018 · 549 citations

Medicine, Cardiology, Surgery +17

AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro

Bartosz Szczęsny, Katalin Módis, Kazunori Yanagi et al. · Nitric Oxide · 2014 · 288 citations

Life Sciences, Biochemistry, Cell Biology +17

Effect of vitamin B6 on oxygen radicals, mitochondrial membrane potential, and lipid peroxidation in H2O2-treated U937 monocytes

Krishnaswamy Kannan, Sushil K. Jain · Free Radical Biology and Medicine · 2003 · 200 citations

Life Sciences, Biochemistry, Cell Biology +17

AP39, a mitochondria-targeting hydrogen sulfide (H₂S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling

Qutuba G. Karwi, Julia Bornbaum, Kerstin Boengler et al. · British Journal of Pharmacology · 2016 · 99 citations · Full text

Life Sciences, Cardiology, Pharmacology +16